309 related articles for article (PubMed ID: 31666932)
1. Splicing regulatory factors in breast cancer hallmarks and disease progression.
Koedoot E; Wolters L; van de Water B; Dévédec SEL
Oncotarget; 2019 Oct; 10(57):6021-6037. PubMed ID: 31666932
[TBL] [Abstract][Full Text] [Related]
2. Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.
Dai X; Xiang L; Li T; Bai Z
J Cancer; 2016; 7(10):1281-94. PubMed ID: 27390604
[TBL] [Abstract][Full Text] [Related]
3. Hallmarks of alternative splicing in cancer.
Oltean S; Bates DO
Oncogene; 2014 Nov; 33(46):5311-8. PubMed ID: 24336324
[TBL] [Abstract][Full Text] [Related]
4. The Chemopreventive Activity of Indonesia Medicinal Plants Targeting on Hallmarks of Cancer.
Meiyanto E; Larasati YA
Adv Pharm Bull; 2019 Jun; 9(2):219-230. PubMed ID: 31380247
[TBL] [Abstract][Full Text] [Related]
5. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review.
García-Chico C; López-Ortiz S; Peñín-Grandes S; Pinto-Fraga J; Valenzuela PL; Emanuele E; Ceci C; Graziani G; Fiuza-Luces C; Lista S; Lucia A; Santos-Lozano A
Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612320
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.
Galloway NR; Ball KF; Stiff T; Wall NR
Crit Rev Oncog; 2017; 22(1-2):23-36. PubMed ID: 29604934
[TBL] [Abstract][Full Text] [Related]
8. The contribution of tumour-derived exosomes to the hallmarks of cancer.
Meehan K; Vella LJ
Crit Rev Clin Lab Sci; 2016; 53(2):121-31. PubMed ID: 26479834
[TBL] [Abstract][Full Text] [Related]
9. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.
Pradella D; Naro C; Sette C; Ghigna C
Mol Cancer; 2017 Jan; 16(1):8. PubMed ID: 28137272
[TBL] [Abstract][Full Text] [Related]
10. Hallmarks of cancer: the next generation.
Hanahan D; Weinberg RA
Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.
Sasahira T; Kirita T
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115834
[TBL] [Abstract][Full Text] [Related]
12. Splicing factors: Insights into their regulatory network in alternative splicing in cancer.
Du JX; Zhu GQ; Cai JL; Wang B; Luo YH; Chen C; Cai CZ; Zhang SJ; Zhou J; Fan J; Zhu W; Dai Z
Cancer Lett; 2021 Mar; 501():83-104. PubMed ID: 33309781
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer RNA-seq data stratifies tumours by some hallmarks of cancer.
Frost FG; Cherukuri PF; Milanovich S; Boerkoel CF
J Cell Mol Med; 2020 Jan; 24(1):418-430. PubMed ID: 31730267
[TBL] [Abstract][Full Text] [Related]
14. Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine.
Rahman MA; Nasrin F; Bhattacharjee S; Nandi S
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481522
[TBL] [Abstract][Full Text] [Related]
15. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
17. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.
Tanaka N; Yoshida H; Suzuki Y; Harigaya K
Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer.
VanDyke D; Kyriacopulos P; Yassini B; Wright A; Burkhart E; Jacek S; Pratt M; Peterson CR; Rai P
Int J Nano Stud Technol; 2016; Suppl 4():1-18. PubMed ID: 27547592
[TBL] [Abstract][Full Text] [Related]
19. Alterations of pre-mRNA splicing in cancer.
Kalnina Z; Zayakin P; Silina K; Linē A
Genes Chromosomes Cancer; 2005 Apr; 42(4):342-57. PubMed ID: 15648050
[TBL] [Abstract][Full Text] [Related]
20. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
